Cutler Group LP Sesen Bio, Inc. Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Apr 14, 2022	SELL	$0.58 - $0.86 $13,687 - $20,296	-23,600 Reduced 99.16%	200 $0
Q4 2021 Jan 18, 2022	SELL	$0.73 - $1.28 $32,339 - $56,704	-44,300 Reduced 65.05%	23,800 $29,000
Q3 2021 Oct 26, 2021	BUY	$0.77 - $4.91 $19,096 - $121,768	24,800 Added 57.27%	68,100 $69,000
Q2 2021 Jul 19, 2021	BUY	$2.18 - $4.66 $66,926 - $143,062	30,700 Added 243.65%	43,300 $22,000
Q1 2021 Apr 26, 2021	BUY	$1.3 - $3.24 $16,380 - $40,824	12,600 New	12,600 $4,000
Q1 2019 May 10, 2019	SELL	$0.69 - $1.47 $690 - $1,470	-1,000 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$1.04 - $3.29 $1,040 - $3,290	1,000 New	1,000 $5,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.